EGFR and lung adenocarcinoma: Some specific lung cancer-associated mutations, in particular, in epidermal growth factor receptor (EGFR), are known to occur more frequently among patients with no history of smoking [9], and are found as clonal driver mutations in lung adenocarcinomas [10].